[A single-center study on the clinical characteristics of 15 cases of large granular lymphocytic leukemia] [0.03%]
单中心15例大颗粒淋巴细胞白血病临床特点分析
X Xie,H L Li,Q Wang et al.
X Xie et al.
This study retrospectively analyzed the clinical data of 15 patients diagnosed with large granular lymphocytic leukemia (LGLL) at the First Affiliated Hospital of Chongqing Medical University between January 2017 and December 2024. The medi...
[Comparison of the efficacy and safety of venetoclax plus azacitidine versus D-CAG regimen in the treatment of elderly patients with relapsed or refractory acute myeloid leukemia] [0.03%]
维奈托克片联合地西他滨和阿扎胞苷与D-CAG方案治疗老年复发难治急性髓系白血病患者的疗效及安全性比较
Z Y Liu,X G Chu,G P Dong et al.
Z Y Liu et al.
Objective: To compare the efficacy and safety of venetoclax (VEN) combined with azacitidine (AZA) (VA) versus decitabine combined with cytarabine+aclarubicin+granulocyte colony-stimulating factor (CAG) (D-CAG) regimen in the treatment of el...
Randomized Controlled Trial
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi. 2026 Mar 14;47(3):262-269. DOI:10.3760/cma.j.cn121090-20250512-00224 2026
[Clinical characteristics and prognosis analysis of newly diagnosed multiple myeloma with t (4;14)] [0.03%]
t(4;14)染色体易位的新诊断多发性骨髓瘤的临床特征及预后分析
R Guo,X Cheng,X X Shen et al.
R Guo et al.
Objective: This study aimed to analyze the clinical characteristics and prognosis of patients with newly diagnosed multiple myeloma (NDMM) with t (4;14) . Methods: Data of 431 patients with NDMM diagnosed in the First Affiliated Hospital of...
[The influence of different collagenases on the analysis of immune cells in salivary glands of mice with chronic graft-versus-host disease] [0.03%]
不同胶原酶对小鼠慢性移植物抗宿主病涎腺免疫细胞分析影响的研究
Z Y Hu,Q X Song,S J Yang et al.
Z Y Hu et al.
Objective: To preliminarily explore the influence of different collagenases on the analysis of immune cells in salivary glands of mice with chronic graft-versus-host disease (cGVHD) . Methods: A major histocompatibility complex mismatch mod...
[Analysis of the disease burden of Burkitt lymphoma in China from 1990 to 2021] [0.03%]
1990年至2021年我国Burkitt淋巴瘤疾病负担分析
C H Zheng,Y Wang,J Chen et al.
C H Zheng et al.
Objective: This study aimed to analyze the disease burden and trends of Burkitt lymphoma (BL) in China between 1990 and 2021. Methods: Based on the 2021 Global Burden of Disease Study data, stratified by age, sex, and region, the disease bu...
[Variables associated with severe cytopenia in adult chronic phase chronic myeloid leukemia patients receiving initial tyrosine kinase inhibitors] [0.03%]
慢性粒细胞白血病酪氨酸激酶抑制剂初治患者严重骨髓毒性相关因素分析
G R Chai,L Yu,Z R Li et al.
G R Chai et al.
Objective: To explore the variables associated with severe cytopenia in patients with chronic phase chronic myeloid leukemia (CML-CP) receiving initial tyrosine kinase inhibitor (TKI) therapy. Methods: Data from consecutive patients aged ≥...
[Treatment practice and outcomes in 125 patients with autoimmune hemolytic anemia: a single-center retrospective analysis] [0.03%]
[自身免疫性溶血性贫血的治疗及预后分析(125例单中心回顾性研究)]
F Yang,R N Li,L L Zhang et al.
F Yang et al.
Objective: To explore the clinical characteristics, treatment patterns, and outcomes of patients with autoimmune hemolytic anemia (AIHA) in a single-center retrospective cohort. Methods: Clinical data of 125 patients with AIHA admitted to t...
[Impact of conditioning intensity on transplant outcomes following allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic neoplasms: a multicenter retrospective cohort study] [0.03%]
Conditioning强度对骨髓增生性肿瘤异基因造血干细胞移植预后影响的多中心回顾队列研究
L Wang,Z L Zhang,R X Zhang et al.
L Wang et al.
Objective: To investigate the effect of transplant conditioning intensity (TCI) on transplant outcomes in patients with myelodysplastic neoplasms (MDS) undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) . Methods: Thi...
[Chinese expert consensus on the diagnosis and treatment of CD5-positive diffuse large B-cell lymphoma (2026)] [0.03%]
中国CD5阳性弥漫大B细胞淋巴瘤诊断治疗专家共识(2023)
Lymphoid Disease Group, Chinese Society of Hematology, Chinese Medical Association;Lymphoma Expert Committee of China Anti-Cancer Association
Lymphoid Disease Group
CD5-positive diffuse large B-cell lymphoma (CD5(+) DLBCL) is a rare immunophenotypic subtype of DLBCL, typically characterized by high aggressiveness, rapid disease progression, and poor prognosis. Even in the era of rituximab-based immunoc...
[Guidelines for the diagnosis and management of first relapsed multiple myeloma in China (2026)] [0.03%]
中国多发性骨髓瘤一线复发诊断和治疗指南（2023年版）
Plasma Cell Disease Group, Chinese Society of Hematology, Chinese Medical Association;Chinese Myeloma Committee-Chinese Hematology Association
Plasma Cell Disease Group
Multiple myeloma (MM) remains an incurable malignancy, and treatment choices after the first relapse are crucial for patients' prognosis. Over the past three years, multiple novel drugs for MM have been approved in China. Based on the first...